Aiberry AI Mental Health Screening Platform

Stopped early

Conditions studied: Depression, Anxiety, Healthy

In brief

Aiberry is creating a multi-modal artificial intelligence (AI) platform that analyzes facial, audio and text features to screen for mental illness. This multicenter study will be used to collect data to validate the platform's ability to detect depression and anxiety in a diverse patient population.

Key facts

Study ID

NCT04994899

Run by

Aiberry, Inc

People needed

800

Starts

2022-09-22

Expected to finish

2023-04-06

Last updated by the study team

2023-06-09

Who can join

Age: 13 and older, up to 79. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 13 to 79 years old
• English-speaking

You may not qualify if…

• Previous participant in the study, within the last three months
• Individuals unable to verbally respond to standardized questions
• Individuals unable to participate in a virtual visit as they do not have the right hardware (phone/laptop) or no internet connectivity
• Individuals unable to provide consent

Where it is running

• University of Arizona — Tucson, Arizona, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Hapworth Research Inc. — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.